Beginning Cash: The amount of cash reported by the company on its previous statement.
Nautilus Biotechnology, Inc. (NAUT) had Beginning Cash of $28.65M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-16.61M |
|
-- |
|
-- |
|
$18.84M |
|
$-18.84M |
|
$2.23M |
|
$-16.61M |
|
$-16.61M |
|
$-16.61M |
|
$-16.61M |
|
$-16.61M |
|
$-16.61M |
|
$-18.84M |
|
$-17.76M |
|
126.14M |
|
126.14M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$141.60M |
|
$3.79M |
|
$86.09M |
|
$227.69M |
|
$8.16M |
|
-- |
|
$25.10M |
|
$33.26M |
|
$194.44M |
|
$194.44M |
|
$194.44M |
|
126.15M |
|
| Cash Flow Statement Financials | |
$-13.94M |
|
$19.51M |
|
$0.02M |
|
|
Beginning Cash |
$28.65M |
$34.24M |
|
$5.59M |
|
$2.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.54% |
|
-8.54% |
|
-7.30% |
|
-8.54% |
|
$1.54 |
|
$-0.11 |
|
$-0.11 |
|